Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster

The drugmaker continues to make headlines for all the right reasons.Eli Lilly's (LLY -0.55%) name has become somewhat synonymous with its work in diabetes and obesity care. That's understandable. The drugmaker is a leader in these areas, and its most recent medicines, Mounjaro and Zepbound, promise to rack up impressive sales.That said, there is much more to Eli Lilly than its successful efforts in these areas. The company has been looking to break into another challenging field: Alzheimer's disease (AD). E ...